Nektar Therapeutics
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances.
Last updated on
About Nektar Therapeutics
Founded
1990Estimated Revenue
$100M-$250MEmployees
251-1KFunding / Mkt. Cap
$2BCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
San FranciscoState
CaliforniaCountry
United StatesTech Stack (72)
